The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Role of VHL Gene Mutation in Human Cancer
Abstract
Germline inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene causes the von Hippel-Lindau hereditary cancer syndrome, and somatic mutations of this gene have been linked to the development of sporadic hemangioblastomas and clear-cell renal carcinomas. The VHL tumor suppressor protein (pVHL), through its oxygen-dependent polyubiquitylation of hypoxia-inducible factor (HIF), plays a central role in the mammalian oxygen-sensing pathway. This interaction between pVHL and HIF is governed by post-translational prolyl hydroxylation of HIF in the presence of oxygen by a conserved family of Egl-nine (EGLN) enzymes. In the absence of pVHL, HIF becomes stabilized and is free to induce the expression of its target genes, many of which are important in regulating angiogenesis, cell growth, or cell survival. Moreover, preliminary data indicate that HIF plays a critical role in pVHL-defective tumor formation, raising the possibility that drugs directed against HIF or its downstream targets (such as vascular endothelial growth factor) might one day play a role in the treatment of hemangioblastoma and renal cell carcinoma. On the other hand, clear genotype-phenotype correlations are emerging in VHL disease and can be rationalized if pVHL has functions separate from its control of HIF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citationAsparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,415
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
SCF and Cullin/RING H2-Based Ubiquitin Ligases
Deshaies, R. J. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.435 · Cited by 1,242
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940
Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Self-citationStructure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citationHIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.1073440 · Cited by 765
Self-citationInhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Self-citationRegulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Tumour suppression by the human von Hippel-Lindau gene product
Iliopoulos, O., Kibel, A., Gray, S., & Kaelin, W. G. (1995) · Nature Medicine · doi:10.1038/nm0895-822 · Cited by 703
Self-citationBinding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C
Kibel, A., Iliopoulos, O., DeCaprio, J. A., & Kaelin, W. G. (1995) · Science · doi:10.1126/science.7660130 · Cited by 671
Self-citationKallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., Haines, J., Yuen, J. W. M., Collins, D., Majoor-Krakauer, D., et al. (1988) · Nature · doi:10.1038/332268a0 · Cited by 662
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611
Self-citationRenal Tumors in the Birt-Hogg-Dubé Syndrome
Pavlovich, C. P., Walther, M. M., Eyler, R. A., Hewitt, S. M., Zbar, B., Linehan, W. M., & Merino, M. J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200212000-00002 · Cited by 604
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
Ema, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1905 · Cited by 587
Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein
Duan, D. R., Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J. W., Linehan, W. M., & Klausner, R. D. (1995) · Science · doi:10.1126/science.7660122 · Cited by 568
Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Senger, D. R. (1993) · PubMed · Cited by 564
Ivan, M., Haberberger, T., Gervasi, D. C., Michelson, K. S., Günzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R. C., Conaway, J. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192342099 · Cited by 561
Self-citationChen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380050109 · Cited by 556
Aravind, L., & Koonin, E. V. (2001) · Genome Biology · doi:10.1186/gb-2001-2-3-research0007 · Cited by 539
Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit
Pugh, C. W., O'Rourke, J. F., Nagao, M., Gleadle, J. M., & Ratcliffe, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11205 · Cited by 532
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
Maher, E. R., & Kaelin, W. G. (1997) · Medicine · doi:10.1097/00005792-199711000-00001 · Cited by 528
Self-citationDisruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510
Iwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., Conaway, J. W., Klausner, R. D., & Pause, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12436 · Cited by 508
Benjamin, L. E., & Keshet, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8761 · Cited by 506
Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., et al. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)8:4<348::aid-humu8>3.0.co;2-3 · Cited by 506
Pause, A., Lee, S., Worrell, R. A., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., & Klausner, R. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2156 · Cited by 493
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<417::aid-humu8>3.0.co;2-k · Cited by 479
Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachamimov, A. O., Louis, D. N., Gavin, B. J., Kley, N., Kaelin, W. G., & Iliopoulos, O. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80096-9 · Cited by 477
Self-citationShuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., & Zbar, B. (1994) · PubMed · Cited by 471
Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 432
Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressor
Haase, V. H., Glickman, J. N., Socolovsky, M., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1583 · Cited by 424
Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203938 · Cited by 396
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Cellular oxygen sensing by mitochondria: old questions, new insight
Chandel, N. S., & Schumacker, P. T. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.5.1880 · Cited by 391
Hoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382
Lonergan, K. M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R. C., Conaway, J. W., & Kaelin, W. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.732 · Cited by 381
Self-citationLisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., & Krek, W. (1999) · Genes & Development · doi:10.1101/gad.13.14.1822 · Cited by 379
Clifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Foster, K., Prowse, A., van den Berg, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2169 · Cited by 373
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice
Gnarra, J. R., Ward, J. M., Porter, F. D., Wagner, J. R., Devor, D. E., Grinberg, A., Emmert-Buck, M. R., Westphal, H., Klausner, R. D., & Linehan, W. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9102 · Cited by 362
Wiesener, M. S., Münchenhagen, P., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jürgensen, J. S., Gruber, G., Maxwell, P. H., Löning, S. A., et al. (2001) · PubMed · Cited by 356
高橋, 敦. (1994) · Medical Entomology and Zoology · doi:10.11501/3101325 · Cited by 352
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL
Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P., & Krek, W. (2003) · Nature Cell Biology · doi:10.1038/ncb899 · Cited by 339
Wizigmann-Voos, S., Breier, G., Risau, W., & Plate, K. H. (1995) · PubMed · Cited by 326
Vincent, K. A., Shyu, K.-G., Luo, Y., Magner, M., Tio, R. A., Jiang, C., Goldberg, M. A., Akita, G. Y., Gregory, R. J., & Isner, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2255 · Cited by 317
Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Müller, M., Wood, J. M., Martiny‐Baron, G., Unger, C., & Marmé, D. (2000) · PubMed · Cited by 308
Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny‐Baron, G., & Marmé, D. (1996) · PubMed · Cited by 308
Elson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 299
Über eine sehr seltene Erkrankung der Netzhaut: Klinische Beobachtungen
Hippel, E. (1904) · Albrecht von Græfe's Archiv für Ophthalmologie · doi:10.1007/bf01994821 · Cited by 293
Maynard, M. A., Qi, H., Chung, J., Lee, E. H. L., Kondo, Y., Hara, S., Conaway, R. C., Conaway, J. W., & Ohh, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208681200 · Cited by 283
Clifford, S. C., Prowse, A. H., Affara, N. A., Buys, C. H. C. M., & Maher, E. R. (1998) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-# · Cited by 270
Kamura, T., Conrad, M. N., Yan, Q., Conaway, R. C., & Conaway, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.22.2928 · Cited by 269
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 266
Iliopoulos, O., Ohh, M., & Kaelin, W. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11661 · Cited by 260
Self-citationInduction of angiogenesis in a mouse model using engineered transcription factors
Rebar, E. J., Huang, Y., Hickey, R., Nath, A. K., Meoli, D., Nath, S., Chen, B., Xu, L., Liang, Y., Jamieson, A. C., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-795 · Cited by 252
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL−/− tumors
Zimmer, M., Doucette, D., Siddiqui, N., & Iliopoulos, O. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.89.2.2 · Cited by 244
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
Pause, A., Lee, S., Lonergan, K. M., & Klausner, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.993 · Cited by 238
Whaley, J. M., Naglich, J. G., Gelbert, L. M., Hsia, Y. E., Lamiell, J. M., Green, J. S., Collins, D. L., Neumann, H. P. H., Laidlaw, J., & Li, F. P. (1994) · PubMed Central · Cited by 232
Kuznetsova, A. V., Meller, J., Schnell, P. O., Nash, J. A., Ignacak, M. L., Sanchez, Y., Conaway, J. W., Conaway, R. C., & Czyzyk-Krzeska, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436037100 · Cited by 232
Schoenfeld, A., Davidowitz, E. J., & Burk, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8817 · Cited by 230
Brauch, H. B., Weirich, G., Brieger, J., Glavač, D., Rödl, H., Eichinger, M., Feurer, M., Weidt, E. J., Puranakanitstha, C., Neuhaus, C., et al. (2000) · PubMed · Cited by 223
Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209
Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T., & Yao, M. (1994) · PubMed · Cited by 208
Arias-Stella, J., & Valcarcel, J. (1976) · Human Pathology · doi:10.1016/s0046-8177(76)80052-4 · Cited by 205
Koochekpour, S., Jeffers, M., Wang, P. H., Gong, C., Taylor, G. A., Roessler, L. M., Stearman, R., Vasselli, J. R., Stetler-Stevenson, W. G., Kaelin, W. G., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5902 · Cited by 201
Self-citationKondo, K., Yao, M., Yoshida, M., Kishida, T., Shuin, T., Miura, T., Moriyama, M., Kobayashi, K., Sakai, N., Kaneko, S., et al. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10054 · Cited by 196
Vortmeyer, A. O., Gnarra, J. R., Emmert-Buck, M. R., Katz, D., Linehan, W. M., Oldfield, E. H., & Zhuang, Z. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90075-7 · Cited by 189
Gunaratnam, L., Morley, M., Franovic, A., de Paulsen, N., Mekhail, K., Parolin, D. A. E., Nakamura, E., Lorimer, I. A. J., & Lee, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305502200 · Cited by 188
Lubensky, I. A., Gnarra, J. R., Bertheau, P., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1996) · PubMed Central · Cited by 187
de Paulsen, N., Brychzy, A., Fournier, M.-C., Klausner, R. D., Gnarra, J. R., Pause, A., & Lee, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1387 · Cited by 187
Okuda, H., Saitoh, K., Hirai, S.-I., Iwai, K., Takaki, Y., Baba, M., Minato, N., Ohno, S., & Shuin, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107880200 · Cited by 176
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
ZUR FRAGE DER ANGIOMATOSIS RETINæ UND IHRER HIRNKOMPLIKATIONEN
LINDAU, A. (1926) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1926.tb07786.x · Cited by 175
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C., Prowse, A., Chew, S. L., Dahia, P. L., O'Riordan, J. L., & Toledo, S. P. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 172
Li, Z., Na, X., Wang, D., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108269200 · Cited by 171
Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann, B., Karumanchi, S. A., Cohen, H. T., & Sukhatme, V. P. (1998) · PubMed · Cited by 170
Adhesion at a granular surface
Zhou, J. N., Rar, A., Otte, D., & Barnard, J. A. (2000) · Journal of Applied Physics · doi:10.1063/1.1303764 · Cited by 169
Pal, S., Claffey, K. P., Cohen, H. T., & Mukhopadhyay, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26277 · Cited by 162
Mydlo, J. H., Michaeli, J., Cordon‐Cardo, C., Goldenberg, A. S., Heston, W. D. W., & Fair, W. R. (1989) · PubMed · Cited by 158
Lee, S., Chen, D. Y., Humphrey, J. S., Gnarra, J. R., Linehan, W. M., & Klausner, R. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1770 · Cited by 154
Duan, D. R., Humphrey, J. S., Chen, D. Y., Weng, Y., Sukegawa, J., Lee, S., Gnarra, J. R., Linehan, W. M., & Klausner, R. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6459 · Cited by 154
Kishida, T., Stackhouse, T. M., Chen, F., Lerman, M. I., & Zbar, B. (1995) · PubMed · Cited by 148
Zatyka, M., da Silva, N. F., Clifford, S. C., Morris, M. R., Wiesener, M. S., Eckardt, K., Houlston, R. S., Richards, F. M., Latif, F., & Maher, E. R. (2002) · PubMed · doi:10.25405/ncl.34582002 · Cited by 147
Lee, S., Neumann, M., Stearman, R. S., Stauber, R. H., Pause, A., Pavlakis, G. N., & Klausner, R. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1486 · Cited by 147
Lee, J., Dong, S. M., Park, W. S., Yoo, N. J., Kim, C. S., Jang, J., Chi, J. G., Zbar, B., Lubensky, I. A., Linehan, W. M., et al. (1998) · PubMed · Cited by 146
Characterization and comparative analysis of the EGLN gene family
Taylor, M. S. (2001) · Gene · doi:10.1016/s0378-1119(01)00633-3 · Cited by 145
Gallou‐Kabani, C., Joly, D., JEAN, A. M., Staroz, F., Martin, N., Tarlet, G., Orfanelli, M.-T., Bouvier, R., Droz, D., tien, Y. C., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:6<464::aid-humu6>3.0.co;2-a · Cited by 144
Sang, N., Fang, J., Srinivas, V., Leshchinsky, I., & Caro, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2984-2992.2002 · Cited by 143
Jiang, Y., Zhang, W., Kondo, K., Klco, J. M., Martin, T. B. S., Dufault, M. R., Madden, S. F., Kaelin, W. G., & Nacht, M. (2003) · PubMed · Cited by 139
Self-citationBlankenship, C., Naglich, J. G., Whaley, J. M., Seizinger, B. R., & Kley, N. (1999) · Oncogene · doi:10.1038/sj.onc.1202473 · Cited by 138
Mutations in the VHL gene in sporadic apparently congenital polycythemia
Pastore, Y. D., Jelinek, J., Ang, S., Guan, Y., Liu, E., Jedlickova, K., Krishnamurti, L., & Prchal, J. T. (2003) · Blood · doi:10.1182/blood-2002-06-1843 · Cited by 136
VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.
Bindra, R. S., Vasselli, J. R., Stearman, R. S., Linehan, W. M., & Klausner, R. D. (2002) · PubMed · Cited by 127
Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00534-x · Cited by 122
Flamme, I., Krieg, M., & Plate, K. H. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65541-1 · Cited by 119
Schnell, P. O., Ignacak, M. L., Bauer, A. L., Striet, J. B., Paulding, W. R., & Czyzyk‐Krzeska, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01696.x · Cited by 107
Davidowitz, E. J., Schoenfeld, A. R., & Burk, R. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.865-874.2001 · Cited by 106
Olschwang, S., Richard, S., Boisson, C., Giraud, S., Laurent‐Puig, P., Resche, F., & Thomas, G. D. (1998) · Human Mutation · Cited by 105
Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
Richards, F., Schofield, P. N., Fleming, S., & Maher, E. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.639 · Cited by 104
Bender, B., Gutsche, M., Gläsker, S., Müller, B., Kirste, G. R., Eng, C., & Neumann, H. P. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7015 · Cited by 103
Okuda, H., Hirai, S.-I., Takaki, Y., Kamada, M., Baba, M., Sakai, N., Kishida, T., Kaneko, S., Yao, M., Ohno, S., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1347 · Cited by 100
Lieubeau, B., Rak, J. W., Jothy, S., Iliopoulos, O., Kaelin, W. G., & Kerbel, R. S. (1998) · PubMed · Cited by 91
Self-citationExpression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma
Böhling, T., Hatva, E., Kujala, M., Claesson, L., Alitalo, K. K., & Haltia, M. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199605000-00004 · Cited by 89
Germline mutations in the vhl gene in patients presenting with phaeochromocytomas
van der Harst, E., de Krijger, R. R., Dinjens, W. N. M., Weeks, L., Bonjer, H. J., Bruining, H. A., Lamberts, S. W. J., & Koper, J. W. (1998) · International Journal of Cancer · Cited by 87
Brauch, H. B., Hoeppner, W., Jähnig, H., Wöhl, T., Engelhardt, D., Spelsberg, F. W., & Ritter, M. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4454 · Cited by 84
Expression of Vascular Endothelial Growth Factor in Capillary Hemangioblastoma
Morii, K., Tanaka, R., Washiyama, K., Kumanishi, T., & Kuwano, R. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1885 · Cited by 84
Datta, K., Nambudripad, R., Pal, S., Zhou, M., Cohen, H. T., & Mukhopadhyay, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909970199 · Cited by 84
Esteban-Barragán, M. A., Ávila, P., Álvarez-Tejado, M., Gutiérrez, M. D. C., García-Pardo, A., Sánchez‐Madrid, F., & Landázuri, M. O. (2002) · PubMed · Cited by 83
Milunsky, J. M., Maher, T. A., Michels, V. V., & Milunsky, A. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1270 · Cited by 83
Gläsker, S. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.5.644 · Cited by 82
The von Hippel-Lindau Tumor Suppressor Stabilizes Novel Plant Homeodomain Protein Jade-1
Zhou, M. I., Wang, H., Ross, J. J., Kuzmin, I., Xu, C., & Cohen, H. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205040200 · Cited by 81
Putative Control of Angiogenesis in Hemangioblastomas by the von Hippel-Lindau Tumor Suppressor Gene
Stratmann, R., Krieg, M., HAAS, R., & Plate, K. H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00009 · Cited by 81
Igarashi, H., Esumi, M., Ishida, H., & Okada, K. (2002) · Cancer · doi:10.1002/cncr.10635 · Cited by 81
The VHL protein recruits a novel KRAB‐A domain protein to repress HIF‐1α transcriptional activity
Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg173 · Cited by 79
Hofstra, R. M. W., Stelwagen, T., Stulp, R. P., Jong, D. D., Hulsbeek, M. M. F., Kamsteeg, E.-J., van den Berg, A., Landsvater, R. M., Vermey, A., Molenaar, W. M., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768845 · Cited by 79
Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Drevs, J., Medinger, M., Schmidt-Gersbach, C., Weber, R., & Unger, C. (2003) · Current Drug Targets · doi:10.2174/1389450033346885 · Cited by 78
de Paulsen, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031587498 · Cited by 78
Tse, J. Y. M., Wong, J. H. C., Lo, K. W., Poon, W. S., Huang, D. P., & Ng, H. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.4.459 · Cited by 72
Bender, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4568 · Cited by 70
A clinical and molecular genetic analysis of solitary ocular angioma
Webster, A. R., Maher, E. R., Bird, A. C., Gregor, Z. J., & Moore, A. T. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90127-6 · Cited by 66
Kroll, S. L., Paulding, W. R., Schnell, P. O., Barton, M. C., Conaway, J. W., Conaway, R. C., & Czyzyk-Krzeska, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30109 · Cited by 64
Bar, M., Friedman, E., Jakobovitz-Picard, O., Leibowitz, G., Lerer, I., Abeliovich, D., & Gross, D. J. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3251150.x · Cited by 59
Familial non-VHL non-papillary clear-cell renal cancer
Teh, B. T., Giraud, S., Sari, N. F., Hii, S.-I., Bergerat, J. P., Larsson, C., Limacher, J. M., & Nicol, D. L. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61751-5 · Cited by 54
Reifenberger, G., REIFENBERGER, J., Bilzer, T., Wechsler, W., & Collins, V. P. (1995) · Europe PMC (PubMed Central) · Cited by 53
Brauch, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4101 · Cited by 51
Richard, S., Croisille, L., Yvart, J., Casadeval, N., Eschwège, P., Aghakhani, N., David, P., Gaudric, A., Scigalla, P., & Hermine, O. (2002) · Blood · doi:10.1182/blood.v99.10.3851 · Cited by 48
Zhuang, Z., Emmert‐Buck, M. R., Roth, M. J., Gnarra, J. R., Linehan, W. M., Liotta, L. A., & Lubensky, I. A. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90368-8 · Cited by 48
Aspects of altered metabolism in children with cancer
Picton, S. V. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(1998)78:11+<62::aid-ijc17>3.0.co;2-v · Cited by 47
Renbaum, P., Duh, F.-M. C., Latif, F., Zbar, B., Lerman, M. I., & Kuzmin, I. (1996) · Human Genetics · doi:10.1007/s004390050281 · Cited by 47
Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent
Ye, Y., Vasavada, S. P., Kuzmin, I., Stackhouse, T. M., Zbar, B., & Williams, B. R. G. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980925)78:1<62::aid-ijc11>3.0.co;2-7 · Cited by 45
HAMANO, K., Esumi, M., Igarashi, H., Chino, K., Mochida, J., ISHIDAand, H., & Okada, K. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(01)69132-8 · Cited by 43
Von Hippel‐Lindau gene alterations in sporadic benign and malignant pheochromocytomas
Dannenberg, H., de Krijger, R. R., van der Harst, E., Abbou, M., Ijzendoorn, Y., Komminoth, P., & Dinjens, W. N. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11060 · Cited by 40
Zhuang, Z., Gnarra, J. R., Dudley, C. F., Zbar, B., Linehan, W. M., & Lubensky, I. A. (1996) · PubMed · Cited by 37
Gijtenbeek, J. M. M., Jacobs, B., Sprenger, S. H. E., Eleveld, M. J., van Kessel, A. G., Kros, J. M., Sciot, R., Calenbergh, F. V., Wesseling, P., & Jeuken, J. W. M. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.4.0977 · Cited by 33
Solitary retinal capillary hemangioma: Lack of genetic evidence for von Hippel-Lindau disease
Singh, A. D., Ahmad, N. R. B. B. N., Shields, C. L., & Shields, J. A. (2002) · Ophthalmic Genetics · doi:10.1076/opge.23.1.21.2201 · Cited by 27
Foster, K., Osborne, R. J., Huddart, R. A., Affara, N. A., Ferguson-Smith, M. A., & Maher, E. R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00437-8 · Cited by 23
Wiesener, M. S., & Eckardt, K. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.356 · Cited by 17
Zhuang, Z., Roth, M. J., Emmert-Buck, M. R., et al. (1994) · PubMed · Cited by 16
KAWAFUCHI, J.-I., Shirakura, T., Azuma, M., TSUNODA, T., & Maekawa, T. (1970) · Annals of Hematology · doi:10.1007/bf01632856 · Cited by 14
Bauer, A. L., Paulding, W. R., Striet, J. B., Schnell, P. O., & Czyzyk-Krzeska, M. (2002) · PubMed · Cited by 13
Cited by
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
Metadata
- Authors
- Kim, W. Y., & Kaelin, W. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-12-15
- Volume
- 22
- Issue
- 24
- Pages
- 4991-5004
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2015644147
- Cited by
- 943
- References
- 171
- FWCI
- 18.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.